Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Diabetes

GLP-1 Drugs For Obesity Treatment Reduce Bariatric Surgeries By 25%: Study

The study noted that a vast majority of obese patients, strikingly 94.7%, received neither form of treatment, while 5% received GLP-1 RAs and 0.3% received surgery.

Medical Daily

Meal Timing Matters For Diabetes: Study Recommends Time-Restricted Eating For Blood Sugar Control

The researchers recommend adopting time-restricted eating as an alternative dietary strategy for diabetic patients were individualized dietary plans do not work or cannot be accessed.

Medical Daily

'Starve yourself': weight stigma harms health treatment

Doctors are accused of placing too much focus on weight when treating women with polycystic ovary syndrome, which researchers warn is affecting quality of care.

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

Diabetes Onset Before 40 Raises Risk Of Death To Four Times: Study

Diagnosing diabetes before 40 quadrupled the risk of early death and later onset was linked to a one-and-a-half times higher risk of death compared with the general population without the condition.

Medical Daily

Doctors urged to look out for weight loss jab ‘misuse’

The medicines regulator has also urged medics to warn patients of side effects.

Evening Standard

Even Single Jog Reduces Diabetes Risk, Benefits Notable By Next Day: Says Study

The study reveals that even a single bout of exercise could help reduce type 2 diabetes risk factors, with benefits notable by the next day.

Medical Daily

Fine businesses not following anti-obesity rules on healthy food, peers say

The proposals came from the Lords’ Food, Diet and Obesity Committee.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Is Eli Lilly Still a Top Healthcare Stock After Its Blockbuster Drug Approval?

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

StockNews.com

Reducing child, teen obesity can save $7b health costs

Reducing the rate of overweight and obesity in Australian kids and teenagers by five per cent could save them more than $7 billion in lifelong health costs.

AAP

Labour push SNP to give Scots weight-loss jabs on NHS

LABOUR are urging the SNP to mimic their plans to tackle obesity with weight-loss jabs.

The National (Scotland)

Scientists warn of food that may be particularly harmful for people with diabetes

Diet sodas, processed cookies and cereals strongly linked to higher blood sugar levels in people with type 2 diabetes

The Independent UK

Wes Streeting says weight-loss jabs for unemployed not 'dystopian'

THE UK’s Health Secretary has denied his plans to give weight-loss jabs to unemployed people would result in a “dystopian future”.

The National (Scotland)

Wes Streeting denies ‘dystopian future’ over weight-loss jabs for unemployed

UK health secretary says people will not be ‘involuntarily jabbed’ but that medications could be ‘gamechanging’

The Guardian - UK

Experts weigh in on Labour plan to offer weight loss jabs to unemployed

LABOUR plans to give obese and unemployed people weight-loss jabs as part of a drive to get them back into work and reduce pressure on the NHS…

The National (Scotland)

Get all your
news in one place.

100’s of premium titles.
One news app.

Woman & Home

No, PCOS doesn't 'go away' after menopause - plus the other myths you need to know about

PCOS and menopause are rarely discussed, yet it could affect 1 in 10 women in the UK. Here, Health Writer Sarah Finley reveals what you need to know

The Guardian - UK

Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn

Scientists say using the drugs to get people back into work could carry logistical and ethical problems

The Guardian - US

Weight-loss drugs could be key reason why US obesity rates falling, experts say

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts

The Independent UK

Weight loss drug Ozempic and type 2 diabetes jabs could be used to tackle binge drinking

Doctors and NHS England’s chief warned this week demand for weight-loss jabs could overwhelm the health services

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Weight-loss drugs not the ‘holy grail’ for obesity crisis, says NHS England director

‘We cannot treat our way out of this’, says Stephen Powis, as doctors warn demand could overwhelm health service

The Guardian - UK

Weight-loss drug firm accused of prioritising profits after halting insulin pen production

Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners

The Independent UK

Doctors’ warning over weight-loss jabs on NHS

Health secretary Wes Streeting has said weight-loss jabs like Wegovy could be given to those who are unemployed

The National (Scotland)

Unemployed to be given weight-loss jags as part of UK plan to 'get them back to work'

THE Health Secretary has said unemployed people will be given weight-loss injections as part of a UK Government drive to “get them back to…

Evening Standard

OPINION - The idea of using weight-loss drugs to get people back into work fills me with deep unease

There was a moment a couple of years ago, as weight-loss injections first erupted into popular consciousness, when it looked as though they couldn’t possibly endure. All right-thinking people were, it seemed, reflexively horrified by the suddenly rampant use and abuse of Ozempic and its compatriots by Hollywood elites. Disturbing…

The Independent UK

Unemployed to be given weight-loss jab to help them back into work

The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro

The Independent UK

Expect employers to get more picky about who you see for care

A nonprofit finds in a recent survey that large employers expect the cost to treat patients will jump nearly 8% next year

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

125 stories

OHA

20 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.